Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.61 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | ALPL | P05186 | 1/20 | 0.60 |
| ▸ | ALPI | P09923 | 1/20 | 0.60 |
| ▸ | ALPG | P10696 | 1/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | PLEC | Q15149 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 13/20 | 0.51 |
| ▸ | CA1 | P00915 | 11/20 | 0.51 |
| ▸ | CA2 | P00918 | 11/20 | 0.51 |
| ▸ | CA12 | O43570 | 4/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.45 |
| ▸ | CDC25A | P30304 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14393164 | 0.93 | USP2 (0.73) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| 6-Carboxyfluorescein SCHEMBL9906208 | 0.86 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| 6-Carboxyfluorescein SCHEMBL29369299 | 0.86 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL12045940 | 0.85 | USP2 (0.68) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL13384808 | 0.85 | USP2 (0.85) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL12458517 | 0.85 | USP2 (0.58) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL19886589 | 0.85 | USP2 (0.62) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL14148863 | 0.84 | USP2 (0.60) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL20254033 | 0.84 | USP2 (0.77) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL107875 | 0.83 | USP2 (0.76) | USP2L3MBTL1DNASE1L3PRMT1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220314-A1 | POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE | Sony Group Corporation (JP) | 2022-07-14 | — | — | US | disclosed |
| EP-3283499-B1 | DUAL QUENCHER PROBES | BIOSEARCH TECH INC (US) | 2022-07-06 | — | — | EP | disclosed |
| EP-3670523-B1 | 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND THEIR USE IN METHODS FOR NUCLEIC ACID SEQUENCING | AGILENT TECHNOLOGIES INC (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20210040145-A1 | MEANS AND METHODS FOR SITE-SPECIFIC FUNCTIONALIZATION OF POLYPEPTIDES | UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) | 2021-02-11 | — | — | US | disclosed |
| US-10745437-B2 | Means and methods for site-specific functionalization of polypeptides | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2020-08-18 | — | — | US | disclosed |
| US-8766238-B2 | Polymeric anions/cations | MERCK PATENT GMBH (DE) | 2014-07-01 | — | — | US | disclosed |
| EP-2455457-A2 | Covalent tethering of functional groups to proteins | PROMEGA CORPORATION (US) | 2012-05-23 | — | — | EP | disclosed |
| EP-2369006-A1 | Covalent tethering of functional groups to proteins | Promega Corporation (US) | 2011-09-28 | — | — | EP | disclosed |
| US-7550582-B2 | labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2009-06-23 | — | — | US | disclosed |
| US-20080070258-A1 | labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2008-03-20 | — | — | US | disclosed |
| US-7217531-B2 | Multiplex analysis using membrane-bound sensitizers | MONOGRAM BIOSCIENCES (US) | 2007-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220314-A1 | POLYMERIC DYES WITH LINKER GROUPS COMPRISING DEOXYRIBOSE | H1-0, POLM, H1-2 | USP2 3575/4885L3MBTL1 7/4885DNASE1L3 123/4885 |
| US-20210040145-A1 | MEANS AND METHODS FOR SITE-SPECIFIC FUNCTIONALIZATION OF POLYPEPTIDES | PTMS, DNPEP, LNPEP | USP2 1380/4885L3MBTL1 630/4885DNASE1L3 2391/4885 |
| US-10745437-B2 | Means and methods for site-specific functionalization of polypeptides | PTMS, DNPEP, LNPEP | USP2 1380/4885L3MBTL1 630/4885DNASE1L3 2391/4885 |
| US-20080070258-A1 | labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents | NPPA, PNKP, PHAX | USP2 4870/4885L3MBTL1 2662/4885DNASE1L3 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.